MISSISSAUGA, ON, Oct. 18, 2013 /CNW/ - Novo Nordisk today announced that Health Canada has approved Levemir ® FlexTouch ®, a disposable prefilled insulin pen containing Levemir ® (insulin detemir).
First Insulin Pen with No Push-Button Extension Now Available Novo Nordisk announced the availability of the Levemir (insulin detemir [rDNA origin] injection) FlexTouch, a new prefilled insulin ...
The US Food and Drug Administration (FDA) has approved Novo Nordisk's prefilled insulin pens NovoLog (insulin aspart [rDNA origin] injection) FlexTouch and Levemir (insulin detemir [rDNA origin] ...
Novo Nordisk announced that the FDA has approved NovoLog (insulin aspart [rDNA origin] injection) FlexTouch and Levemir (insulin detemir [rDNA origin] injection) FlexTouch, its two new prefilled ...
PLAINSBORO, N.J., June 19, 2014 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, today announced the availability of its newest prefilled insulin delivery device Levemir ® FlexTouch ® ...
The approval was also announced at the 2013 Vascular Conference in Montreal, Quebec.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback